- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07602621
Video-Assisted Emotional Preparation and Emotional Expression During Subcutaneous Procedures in Children With Cancer
The Effect of Video-Assisted Emotional Preparation on Emotional Expression in Children With Cancer Undergoing Subcutaneous Procedures
The goal of this randomized controlled trial is to evaluate whether video-assisted emotional preparation helps reduce emotional distress in children with leukemia undergoing subcutaneous procedures. The study will also examine whether this intervention affects procedure duration and crying time during the procedure.
The main questions it aims to answer are:
- Does video-assisted emotional preparation improve children's emotional expression during subcutaneous procedures?
- Does the intervention reduce the duration of the procedure?
- Does the intervention shorten crying time during the procedure?
Researchers will compare video-assisted structured emotional preparation with structured emotional preparation alone and routine care to determine the effectiveness of the intervention.
Participants will be randomly assigned to one of three groups:
- video-assisted structured emotional preparation,
- structured emotional preparation only,
- or routine care
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This randomized controlled study aims to evaluate the effect of a video-assisted structured emotional preparation intervention on emotional expression in children aged 3-6 years diagnosed with leukemia who undergo subcutaneous procedures. The study is grounded in atraumatic and child-centered care principles and is based on the idea that developmentally appropriate emotional preparation may help children cope more effectively with stressful medical procedures.
Hospitalization and repeated needle-related procedures are major sources of fear, anxiety, and emotional distress for children with cancer. In particular, preschool children may struggle to understand medical procedures cognitively and tend to interpret experiences through symbolic and imaginative thinking. For this reason, the intervention in this study combines short video-based storytelling with a structured emotional preparation session designed according to children's developmental characteristics. The video presents the subcutaneous procedure through child-friendly metaphors such as "superheroes" and "knights helping the body," aiming to reduce threat perception and support emotional regulation before the procedure.
The study will be conducted in the Pediatric Hematology Clinic of Ege University Children's Hospital with children receiving inpatient leukemia treatment and scheduled for subcutaneous procedures. Participants will be randomly assigned to one of three groups:
- video-assisted structured emotional preparation,
- structured emotional preparation only, and
- routine care control group.
Emotional expression levels, procedure duration, and crying duration will be evaluated across repeated treatment sessions. Emotional responses will be assessed using the Children's Emotional Manifestation Scale (CEMS).
The structured emotional preparation session includes emotional awareness, cognitive reframing, behavioral coping strategies, short behavioral rehearsal, controlled transition, and positive reinforcement. The intervention is designed to be brief, feasible within routine clinical workflow, and easily applicable by pediatric nurses.
By integrating developmentally appropriate visual storytelling and emotional support into pediatric oncology care, this study seeks to contribute evidence regarding non-pharmacological nursing interventions that may reduce distress during invasive procedures and improve children's procedural experiences.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- The child must be between the ages of 3 and 6,
- The child must be receiving inpatient treatment at the Pediatric Hematology Clinic,
- The child must be scheduled to undergo a subcutaneous procedure related to a leukemia diagnosis
- The child and parent must agree to participate in the study and provide written informed consent,
- The child and parent must be able to communicate in basic Turkish,
- At least one parent (mother or father) must be present with the child during the procedure.
Exclusion Criteria:
- Development of an acute or unstable clinical condition
- The child's discharge or continuation of treatment on an outpatient basis
- A single SC procedure performed based on the child's clinical condition
- The child has received sedation or a medication causing confusion prior to the procedure
- The child has severe vision or hearing problems that prevent video viewing or a structured emotional preparation interview
- Another interventional procedure is scheduled for the same day
- Withdrawal of informed consent by the child or parent during the process
- Difficulty adhering to the study protocol (e.g., discontinuing the procedure or refusing the procedure).
- If communication or cooperation issues prevent the completion of research data, the case will be excluded from the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Video-Assisted Structured Emotional Preparation Interview Group
In addition to the structured emotional preparation interview, a short educational video will be shown, followed by a brief discussion about the video.
The screening of the educational video and the brief discussion will be conducted individually by Researcher B in the child's own room.
The video will be shown to the children via a tablet controlled by Researcher B; the video file will not be shared with participants or parents.
Parents will be informed both verbally and in writing that, to preserve the integrity of the study, they must not share the video content with other parents or children or describe it to children in other groups.
Additionally, during the assessments on Days 15 and 30, a brief follow-up question will be asked of the parent: "Have you shared the video with another family so far?
Have you described the content to anyone else? Have you heard any information about this content from another family?"
|
In addition to the structured emotional preparation interview, a short educational video will be shown, followed by a brief discussion about the video.
The screening of the educational video and the brief discussion will be conducted individually by Researcher B in the child's own room.
The video will be shown to the children via a tablet controlled by Researcher B; the video file will not be shared with participants or parents.
Parents will be informed both verbally and in writing that, to preserve the integrity of the study, they must not share the video content with other parents or children or describe it to children in other groups.
Additionally, during the assessments on Days 15 and 30, a brief follow-up question will be asked of the parent: "Have you shared the video with another family so far?
Have you described the content to anyone else? Have you heard any information about this content from another family?"
|
|
Active Comparator: Structured Emotional Preparation Interview Group
In this group, only the structured emotional preparation interview developed by Researcher B will be administered.
Parents in this group will be asked, "Have you watched a video similar to this study, or has such content been described to you?"
This information will be recorded as an indicator of contamination.
|
In this group, the only intervention will be the emotional preparation interview conducted by Researcher B. Parents in this group will be asked, "Have you watched a video similar to this study, or has such content been described to you?"
This information will be recorded as an indicator of contamination.
|
|
No Intervention: Control Group
Children in this group will receive standard clinical care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Emotional Expression
Time Frame: Subcutaneous treatments to be administered on days 0, 15, and 30 will be monitored
|
Children's Emotional Manifestation Scale is used to assess the anxiety children experience during medical procedures.
A total score between 5 and 25 is obtained.
A higher score is associated with higher levels of anxiety.
|
Subcutaneous treatments to be administered on days 0, 15, and 30 will be monitored
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
duration of SC process
Time Frame: Subcutaneous treatments to be administered on days 0, 15, and 30 will be monitored
|
The duration of the subcutaneous injection will be recorded in accordance with the clinical procedure.
This duration will begin immediately before the nurse cleans the skin and end when a cotton ball is placed over the injection site.
|
Subcutaneous treatments to be administered on days 0, 15, and 30 will be monitored
|
|
Duration of crying
Time Frame: Subcutaneous treatments to be administered on days 0, 15, and 30 will be monitored
|
The duration of crying in children during subcutaneous injection will be recorded in accordance with clinical protocol.
|
Subcutaneous treatments to be administered on days 0, 15, and 30 will be monitored
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Unknown2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Leukemia
-
Samsung Medical CenterMinistry of Health, Republic of KoreaRecruitingRelapsed Pediatric AML | Refractory Pediatric AML | Relapsed Pediatric Solid Tumor | Refractory Pediatric Solid TumorKorea, Republic of
-
National Cancer Institute (NCI)CompletedPediatric Leukemia | Other Pediatric CancersUnited States
-
Universiti Kebangsaan Malaysia Medical CentreUniversiti Putra Malaysia; Ministry of Health, MalaysiaCompletedPediatric Hodgkin Lymphoma | Pediatric Acute Myeloid Leukemia | Pediatric Acute Lymphoid Leukemia | Pediatric Non-Hodgkin LymphomaMalaysia
-
Institute of Hematology & Blood Diseases Hospital...RecruitingPediatric Acute LeukemiaChina
-
Emory UniversityTerminatedPediatric Acute Myeloblastic Leukemia, Relapsed | Pediatric Acute Lymphoblastic Leukemia, RelapsedUnited States
-
Virginia Commonwealth UniversityCompletedLymphoma | Acute Lymphoblastic Leukemia | Pediatric ALL | Pediatric Cancer | Pediatric LymphomaUnited States
-
Therapeutic Advances in Childhood Leukemia ConsortiumAbbottTerminatedAcute Lymphoblastic Leukemia | Relapsed Pediatric ALL | Recurrent Pediatric ALL | Refractory Pediatric ALLUnited States
-
Ege UniversityCompletedPediatric ALL | Pediatric Leukemia, Acute MyeloidTurkey
-
Elucida OncologyTherapeutic Advances in Childhood Leukemia and Lymphoma (TACL)WithdrawnAcute Myeloid Leukemia | AML, Childhood | Relapsed Pediatric AML | Refractory Pediatric AML
-
Indiana UniversityNational Institute of Nursing Research (NINR); Ann & Robert H Lurie Children... and other collaboratorsCompletedAcute Lymphoblastic Leukemia, Pediatric | Pediatric CancerUnited States
Clinical Trials on Video-Assisted Structured Emotional Preparation
-
Alev KeskinCukurova UniversityCompletedClinical Skill Training - Peripheral IV Catheter InsertionTurkey (Türkiye)
-
Universidad de la SabanaCompletedCardiopulmonary Resuscitation | Asphyxia Neonatorum | Birth Injuries
-
London School of Hygiene and Tropical MedicineCompletedInformation Seeking BehaviorUnited Kingdom
-
Inonu UniversityActive, not recruitingDental Anxiety | Child Behavior | Dental Fear | Cooperation During Dental TreatmentTurkey (Türkiye)
-
Changhai HospitalUnknownAdenoma Detection Rate | Bowel Preparation ScaleChina
-
Duke UniversityCompletedCancer of the GI System-stages II III and IVUnited States
-
Children's Hospital ColoradoCompletedAnxiety | DistressUnited States
-
Ankara Yildirim Beyazıt UniversityAnkara Etlik City HospitalRecruitingOccupational Burnout | Communication Skills | Emotional AwarenessTurkey (Türkiye)
-
The Second Hospital of Shandong UniversityRecruiting